Pharmafile - Medical Communications News
Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of precision...
The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of the week. They are due to decide whether or...
Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company...
Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional...
BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which aims to develop a multi-...
Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a biosimilar to anti-...
Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however it did not decrease...
On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment of biliary...
Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a New Drug...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
